HK1042695A1 - 蛋白酶抑制劑 - Google Patents
蛋白酶抑制劑Info
- Publication number
- HK1042695A1 HK1042695A1 HK02102419.7A HK02102419A HK1042695A1 HK 1042695 A1 HK1042695 A1 HK 1042695A1 HK 02102419 A HK02102419 A HK 02102419A HK 1042695 A1 HK1042695 A1 HK 1042695A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- prothease
- inhibitors
- prothease inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/16—Eight-membered rings
- C07D313/18—Eight-membered rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12069999P | 1999-02-19 | 1999-02-19 | |
PCT/US2000/004133 WO2000049011A1 (fr) | 1999-02-19 | 2000-02-17 | Inhibiteurs de protease |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1042695A1 true HK1042695A1 (zh) | 2002-08-23 |
Family
ID=22392011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02102419.7A HK1042695A1 (zh) | 1999-02-19 | 2002-03-28 | 蛋白酶抑制劑 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1153022A4 (fr) |
JP (1) | JP2002537297A (fr) |
AU (1) | AU3235100A (fr) |
CO (1) | CO5271679A1 (fr) |
DZ (1) | DZ3083A1 (fr) |
HK (1) | HK1042695A1 (fr) |
PE (1) | PE20001486A1 (fr) |
WO (1) | WO2000049011A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7168084B1 (en) | 1992-12-09 | 2007-01-23 | Sedna Patent Services, Llc | Method and apparatus for targeting virtual objects |
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
WO2001034156A1 (fr) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Inhibiteurs de protease |
EP1232154A4 (fr) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | Inhibiteurs de protease |
US6596715B1 (en) | 1999-11-10 | 2003-07-22 | Smithkline Beecham Corporation | Protease inhibitors |
CA2404206A1 (fr) | 2000-03-21 | 2001-09-27 | Smithkline Beecham Corporation | Inhibiteur de proteinase |
WO2002040462A2 (fr) * | 2000-11-17 | 2002-05-23 | Medivir Uk Limited | Inhibiteurs de cystéine protéase |
EP1358183B1 (fr) * | 2000-11-17 | 2006-04-12 | Medivir Ab | Inhibiteurs de la cysteine protease |
EP1482020B1 (fr) * | 2003-05-27 | 2006-09-06 | MERCK PATENT GmbH | Dérivés de pyrane avec une double liaison exocyclique |
ATE340836T1 (de) | 2003-05-27 | 2006-10-15 | Merck Patent Gmbh | Pyranderivate |
EP1757284A1 (fr) * | 2005-08-25 | 2007-02-28 | Santhera Pharmaceuticals (Schweiz) AG | Utilisation de la N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) pour la prévention ou le traitement de la dystrophie musculaire |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5021432A (en) * | 1988-04-26 | 1991-06-04 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzopyran compound and its pharmaceutical use |
EP0687249A1 (fr) * | 1993-03-03 | 1995-12-20 | Eli Lilly And Company | Balanoides |
US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
AR013079A1 (es) * | 1997-05-06 | 2000-12-13 | Smithkline Beecham Corp | Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios |
-
2000
- 2000-02-16 DZ DZ000030A patent/DZ3083A1/fr active
- 2000-02-17 JP JP2000599751A patent/JP2002537297A/ja not_active Withdrawn
- 2000-02-17 WO PCT/US2000/004133 patent/WO2000049011A1/fr not_active Application Discontinuation
- 2000-02-17 AU AU32351/00A patent/AU3235100A/en not_active Abandoned
- 2000-02-17 EP EP00910222A patent/EP1153022A4/fr not_active Withdrawn
- 2000-02-18 PE PE2000000128A patent/PE20001486A1/es not_active Application Discontinuation
- 2000-02-18 CO CO00011383A patent/CO5271679A1/es not_active Application Discontinuation
-
2002
- 2002-03-28 HK HK02102419.7A patent/HK1042695A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002537297A (ja) | 2002-11-05 |
EP1153022A1 (fr) | 2001-11-14 |
PE20001486A1 (es) | 2001-02-08 |
CO5271679A1 (es) | 2003-04-30 |
EP1153022A4 (fr) | 2002-03-27 |
WO2000049011A1 (fr) | 2000-08-24 |
AU3235100A (en) | 2000-09-04 |
DZ3083A1 (fr) | 2004-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9900416D0 (en) | Inhibitors | |
IL146518A0 (en) | Metalloprotease inhibitors | |
EG23979A (en) | Renin inhibitors | |
IL148820A0 (en) | Fab i inhibitors | |
IL145085A0 (en) | Dihetero-substituted metalloprotease inhibitors | |
EP1153022A4 (fr) | Inhibiteurs de protease | |
EP1235577A4 (fr) | Inhibiteurs de protease | |
GB9924522D0 (en) | Enzyme inhibitors | |
EP1232155A4 (fr) | Inhibiteurs de protease | |
EP1229912A4 (fr) | Inhibiteurs de protease | |
EP1231921A4 (fr) | Inhibiteurs de proteases | |
EP1229915A4 (fr) | Inhibiteurs de protease | |
EP1229914A4 (fr) | Inhibiteurs de protease | |
HK1043534A1 (zh) | 蛋白酶抑制劑 | |
EP1173429A4 (fr) | Inhibiteurs de protease | |
EP1229911A4 (fr) | Inhibiteurs de proteases | |
EP1351930A4 (fr) | Inhibiteurs de la protease | |
EP1233771A4 (fr) | Inhibiteurs de protease | |
GB2389113B (en) | B-secretase inhibitor | |
EP1231923A4 (fr) | Inhibiteurs de protease | |
EP1232154A4 (fr) | Inhibiteurs de protease | |
EP1231922A4 (fr) | Inhibiteurs de protease | |
EP1189618A4 (fr) | Inhibiteurs de la thrombine | |
GB9929341D0 (en) | Inhibitors | |
GB9917294D0 (en) | Inhibitors |